← GLP-1 entry
ENEL-MET-0001
Self-reported metabolic outcomes among current GLP-1 users
Observational, within-person, pre and post baseline
A large reporting population recorded metabolic outcomes against their own baseline. The signal is strong and stable.
Validated
Illustrative sample
Effect index
+0.61
95% CrI
[0.44, 0.77]
Validated n = 1240
Effect index +0.61, 95% confidence interval 0.44 to 0.77
People already using a GLP-1 medicine reported metabolic outcomes against their own baseline. The reporting population is large, the estimate is strong, and the interval is tight.
Non-responders are recorded at 14 percent. This study measures self-reported outcomes, not a controlled trial.